OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Linda Billett is a CMC director of global regulatory affairs at AstraZeneca (Macclesfield).
December 02, 2008
The authors review the current regulatory framework for the selection of drug substance starting materials.